Hematologist
CION Cancer Clinics
Am I eligible for a stem cell transplant for myeloma? | CION Cancer Clinics
There is no single age limit for a myeloma stem cell transplant. Fitness decides it: your heart, lungs, kidneys, other illnesses, everyday activity and how you cope with the first treatment. A fit person in their early seventies may qualify, while a frail younger person may not. Being told a transplant is not right for you still leaves a full, active treatment plan. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Is there an age limit for a myeloma stem cell transplant?
- What does the team actually look at to decide?
- How do the two paths differ?
- What happens between induction and transplant?
- What do families often assume about transplant eligibility?
- How should you approach the conversation, and what can this page not tell you?
- Common questions about transplant eligibility in myeloma
The short answer
Is there an age limit for a myeloma stem cell transplant?
There is no single fixed age cut-off. Fitness matters more than the number on the birth certificate, so a fit person in their early seventies may be offered a transplant while a frail person in their fifties may not.
What kind of transplant this is
In myeloma, the usual transplant is an autologous stem cell transplant. That means your own stem cells are collected from the blood and frozen. You are then given a high dose of a chemotherapy medicine called melphalan, which clears out the marrow, and your own cells are returned by drip to rebuild it. No donor is needed.
Why age still comes up
The high-dose treatment is hard on the body. It leaves you with almost no white cells for a period, with a real risk of serious infection, mouth soreness and weakness. With age, the heart, lungs and kidneys have less in reserve to get through that phase. That is why many teams think carefully once a person is past their late sixties, and weigh each case on its own.
What a transplant can and cannot offer
For people who are fit enough, a transplant usually keeps myeloma under control for longer before it returns. It does not make myeloma go away for good. Modern combinations without a transplant also work well, so being told "not a transplant" is not the same as being told "no good treatment".
The real questions
What does the team actually look at to decide?
Eligibility is a judgement built from several parts. No single test decides it.
Everyday fitness
Can you walk, climb stairs, look after yourself and stay up most of the day? Doctors score this on a scale called performance status. Bone pain from myeloma can lower it for a while, and it may improve with treatment.
Heart and lungs
An echo scan of the heart, an ECG and sometimes breathing tests show whether these organs can cope with the stress of high-dose treatment and infection.
Kidneys and liver
Kidney damage from myeloma does not rule a transplant out by itself. It changes the dose and needs specialist care. Liver function is checked too.
Other illnesses
Diabetes, heart disease, earlier strokes, lung disease and memory problems all count. Two well-controlled conditions matter less than one poorly controlled one.
Response to induction
How well the myeloma responds to the first treatment, and how the body copes with it, is a strong practical test of readiness.
Your wishes and support
A transplant needs weeks near the transplant centre and a carer at home afterwards. What you want, and what the family can manage, belong in the decision.
Not sure whether this applies to you?
Ask an oncologistSide by side
How do the two paths differ?
Transplant-eligible
Not transplant-eligible
A few months of induction, often VRd or a four-drug combination
Induction such as DRd, often continued for as long as it works
Stem cell collection, then high-dose melphalan and transplant
No collection or high-dose phase
A hospital stay at a transplant centre, then gradual recovery
Mostly day-care visits and tablets at home
Maintenance treatment afterwards, often lenalidomide
Treatment adjusted over time to fitness and response
If the answer is yes
What happens between induction and transplant?
-
Induction and response check
Induction runs for its planned number of cycles. Blood and sometimes marrow tests show how far the myeloma has fallen.
-
Referral and fitness tests
The transplant centre repeats heart, lung, kidney and infection checks, and meets you and the family to explain the process.
-
Stem cell collection
Injections move stem cells from the marrow into the blood. A machine then collects them through a line in a vein over one or more days. They are frozen until needed.
-
High-dose treatment and transplant
Melphalan is given, then your cells are returned by drip. The hard stretch follows, while counts are at their lowest and infection risk is highest.
-
Recovery and maintenance
Counts recover, you go home, and energy returns slowly over months. Maintenance treatment usually starts once recovery allows.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often assume about transplant eligibility?
"He is over sixty-five, so a transplant is out of the question."
Age alone does not decide it. Many teams assess fit people well into their late sixties and beyond. Ask for a fitness assessment instead of assuming the answer.
"If they say no to transplant, they are giving up on her."
A "no" means the team believes the risk of high-dose treatment outweighs its benefit for her. Treatment without a transplant is a full, active plan, and many people live well on it for a long time.
"Kidney damage means no transplant."
Kidney damage makes the transplant more complex and changes the dose, but it does not automatically rule it out. Some people's kidneys improve a great deal with induction.
"We need a matching donor from the family first."
The usual myeloma transplant uses your own stem cells, so no donor search is needed. Donor transplants are rarely used in myeloma and only in special situations.
Making the decision
How should you approach the conversation, and what can this page not tell you?
This page cannot tell you whether you are eligible. Only a team that has examined you, seen your tests and watched how you respond to induction can say that. It also cannot tell you how long a transplant would keep the myeloma controlled for you.
Questions worth asking
Ask whether you are being assessed for a transplant now or after induction. Ask which fitness problems, if any, are the main concern, and whether they could improve. Ask when stem cells should be collected, because long exposure to lenalidomide can make collection harder. Ask which transplant centre, how long you would need to stay nearby, and who at home would need to be available.
If the answer is no
Ask what the main reason is, and whether it could change. Ask what the treatment will be instead, how often you will need to visit, and how the team will judge whether it is working. A plan without a transplant is often gentler on daily life, and many families find that matters a great deal.
How CION fits in
CION does not carry out stem cell transplants. The haematology team evaluates the case, presents it at a tumour board, gives induction and coordinates referral to a qualified transplant centre. Care returns to the team for maintenance and follow-up.
Choosing not to have a transplant, even when eligible, is a valid decision. Ask what the plan would look like either way.Questions we are asked
Common questions about transplant eligibility in myeloma
My father is seventy-two. Can he still have a transplant?
Possibly, if he is fit. Some teams offer transplants to carefully selected people in their early seventies, often with a reduced melphalan dose. The deciding points are his heart, lungs, kidneys, daily activity and how he copes with induction. Ask his haematologist for a formal fitness assessment rather than a yes or no based on age.
When is the transplant decision made?
An early view is usually formed at diagnosis, because it shapes which induction is chosen. The final decision is often made after a few cycles, once the response and your tolerance are clear. Fitness can change in either direction during that time, so it is reviewed again before referral.
Can the transplant be done later instead of now?
Sometimes. Some people have stem cells collected and frozen after induction, and keep the transplant for when the myeloma returns. This is called a delayed transplant. Whether it suits you depends on the myeloma's features and your wishes. Collecting cells early keeps that option open.
Does high-risk myeloma change eligibility?
High-risk genetic features do not make you less eligible. They may make the team more keen to use every effective step, including a transplant and stronger maintenance, if you are fit enough. The report terms are explained on our page about high-risk cytogenetics.
How long will we need to stay near the transplant centre?
It varies between centres and between people. Expect a hospital stay of some weeks, then frequent visits while counts recover. Families from districts outside Hyderabad often arrange nearby accommodation. Ask the transplant centre for its own timeline before you plan.
What if we cannot manage the cost of a transplant?
Say so early. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover parts of a transplant, but rules change, so check the current position. The team can also explain what a non-transplant plan involves, so the decision is made on full information.
Can fitness improve enough to become eligible?
Yes, sometimes. Bone pain, kidney strain and weakness caused by active myeloma often improve with induction. Physiotherapy, good nutrition and treatment of other conditions help too. The team reassesses as you improve, so an early "not yet" is not always final.
Is a transplant the only way to get a deep response?
No. Modern combinations without a transplant can also bring the myeloma markers down a long way. A transplant tends to make control last longer for fit people. Your haematologist can explain what each path is likely to mean for someone with your features.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ), Patient Version
- Cancer Research UK — Myeloma
- NHS — Multiple myeloma
- Cancer.Net — Multiple Myeloma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Induction Therapy: VRd, DRd and What They InvolveThe treatment that comes before any transplantMaintenance Therapy After Myeloma TreatmentWhat usually follows a transplantHigh-Risk Cytogenetics in MyelomaHow genetic features shape the planMyeloma in Patients Over 75Treatment when a transplant is not an option
Talk to us
Wondering whether a transplant fits your situation?
Share the reports. CION's haematology team will review the case and explain the options, including referral to a transplant centre where it is right.